Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression

J. D. Duarte, Stephen T Turner, B. Tran, A. B. Chapman, Kent R Bailey, Y. Gong, J. G. Gums, T. Y. Langaee, A. L. Beitelshees, R. M. Cooper-Dehoff, E. Boerwinkle, J. A. Johnson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A recent genome-wide analysis discovered an association between a haplotype (from rs317689/rs315135/rs7297610) on Chromosome 12q15 and blood pressure response to hydrochlorothiazide (HCTZ) in African-Americans. Our aim was to replicate this association and investigate possible functional mechanisms. We observed similar associations between this haplotype and HCTZ response in an independent sample of 746 Caucasians and African-Americans randomized to HCTZ or atenolol treatment. The haplotype association was driven by variation at rs7297610, where C/C genotypes were associated with greater mean (systolic: 3.4 mmHg, P=0.0275; diastolic: 2.5 mmHg, P=0.0196) responses to HCTZ vs T-allele carriers. Such an association was absent in atenolol-treated participants, supporting this as HCTZ specific. Expression analyses in HCTZ-treated African-Americans showed differential pre-treatment leukocyte YEATS4 expression between rs7297610 genotype groups (P=0.024), and reduced post-treatment expression in C/C genotypes (P=0.009), but not in T-carriers. Our data confirm previous genome-wide findings at 12q15 and suggest differential YEATS4 expression could underpin rs7297610-associated HCTZ response variability, which may have future implications for guiding thiazide treatment.

Original languageEnglish (US)
Pages (from-to)257-263
Number of pages7
JournalPharmacogenomics Journal
Volume13
Issue number3
DOIs
StatePublished - Jun 2013

Fingerprint

Chromosomes, Human, Pair 12
Hydrochlorothiazide
Antihypertensive Agents
African Americans
Haplotypes
Atenolol
Genotype
Thiazides
Genome-Wide Association Study
Therapeutics
Leukocytes
Chromosomes
Alleles
Genome
Blood Pressure

Keywords

  • Blood pressure
  • diuretics
  • hydrochlorothiazide
  • hypertension
  • YEATS4

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine
  • Genetics

Cite this

Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression. / Duarte, J. D.; Turner, Stephen T; Tran, B.; Chapman, A. B.; Bailey, Kent R; Gong, Y.; Gums, J. G.; Langaee, T. Y.; Beitelshees, A. L.; Cooper-Dehoff, R. M.; Boerwinkle, E.; Johnson, J. A.

In: Pharmacogenomics Journal, Vol. 13, No. 3, 06.2013, p. 257-263.

Research output: Contribution to journalArticle

Duarte, JD, Turner, ST, Tran, B, Chapman, AB, Bailey, KR, Gong, Y, Gums, JG, Langaee, TY, Beitelshees, AL, Cooper-Dehoff, RM, Boerwinkle, E & Johnson, JA 2013, 'Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression', Pharmacogenomics Journal, vol. 13, no. 3, pp. 257-263. https://doi.org/10.1038/tpj.2012.4
Duarte, J. D. ; Turner, Stephen T ; Tran, B. ; Chapman, A. B. ; Bailey, Kent R ; Gong, Y. ; Gums, J. G. ; Langaee, T. Y. ; Beitelshees, A. L. ; Cooper-Dehoff, R. M. ; Boerwinkle, E. ; Johnson, J. A. / Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression. In: Pharmacogenomics Journal. 2013 ; Vol. 13, No. 3. pp. 257-263.
@article{22051b2af34942638fc4ff250d819489,
title = "Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression",
abstract = "A recent genome-wide analysis discovered an association between a haplotype (from rs317689/rs315135/rs7297610) on Chromosome 12q15 and blood pressure response to hydrochlorothiazide (HCTZ) in African-Americans. Our aim was to replicate this association and investigate possible functional mechanisms. We observed similar associations between this haplotype and HCTZ response in an independent sample of 746 Caucasians and African-Americans randomized to HCTZ or atenolol treatment. The haplotype association was driven by variation at rs7297610, where C/C genotypes were associated with greater mean (systolic: 3.4 mmHg, P=0.0275; diastolic: 2.5 mmHg, P=0.0196) responses to HCTZ vs T-allele carriers. Such an association was absent in atenolol-treated participants, supporting this as HCTZ specific. Expression analyses in HCTZ-treated African-Americans showed differential pre-treatment leukocyte YEATS4 expression between rs7297610 genotype groups (P=0.024), and reduced post-treatment expression in C/C genotypes (P=0.009), but not in T-carriers. Our data confirm previous genome-wide findings at 12q15 and suggest differential YEATS4 expression could underpin rs7297610-associated HCTZ response variability, which may have future implications for guiding thiazide treatment.",
keywords = "Blood pressure, diuretics, hydrochlorothiazide, hypertension, YEATS4",
author = "Duarte, {J. D.} and Turner, {Stephen T} and B. Tran and Chapman, {A. B.} and Bailey, {Kent R} and Y. Gong and Gums, {J. G.} and Langaee, {T. Y.} and Beitelshees, {A. L.} and Cooper-Dehoff, {R. M.} and E. Boerwinkle and Johnson, {J. A.}",
year = "2013",
month = "6",
doi = "10.1038/tpj.2012.4",
language = "English (US)",
volume = "13",
pages = "257--263",
journal = "Pharmacogenomics Journal",
issn = "1470-269X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Association of chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression

AU - Duarte, J. D.

AU - Turner, Stephen T

AU - Tran, B.

AU - Chapman, A. B.

AU - Bailey, Kent R

AU - Gong, Y.

AU - Gums, J. G.

AU - Langaee, T. Y.

AU - Beitelshees, A. L.

AU - Cooper-Dehoff, R. M.

AU - Boerwinkle, E.

AU - Johnson, J. A.

PY - 2013/6

Y1 - 2013/6

N2 - A recent genome-wide analysis discovered an association between a haplotype (from rs317689/rs315135/rs7297610) on Chromosome 12q15 and blood pressure response to hydrochlorothiazide (HCTZ) in African-Americans. Our aim was to replicate this association and investigate possible functional mechanisms. We observed similar associations between this haplotype and HCTZ response in an independent sample of 746 Caucasians and African-Americans randomized to HCTZ or atenolol treatment. The haplotype association was driven by variation at rs7297610, where C/C genotypes were associated with greater mean (systolic: 3.4 mmHg, P=0.0275; diastolic: 2.5 mmHg, P=0.0196) responses to HCTZ vs T-allele carriers. Such an association was absent in atenolol-treated participants, supporting this as HCTZ specific. Expression analyses in HCTZ-treated African-Americans showed differential pre-treatment leukocyte YEATS4 expression between rs7297610 genotype groups (P=0.024), and reduced post-treatment expression in C/C genotypes (P=0.009), but not in T-carriers. Our data confirm previous genome-wide findings at 12q15 and suggest differential YEATS4 expression could underpin rs7297610-associated HCTZ response variability, which may have future implications for guiding thiazide treatment.

AB - A recent genome-wide analysis discovered an association between a haplotype (from rs317689/rs315135/rs7297610) on Chromosome 12q15 and blood pressure response to hydrochlorothiazide (HCTZ) in African-Americans. Our aim was to replicate this association and investigate possible functional mechanisms. We observed similar associations between this haplotype and HCTZ response in an independent sample of 746 Caucasians and African-Americans randomized to HCTZ or atenolol treatment. The haplotype association was driven by variation at rs7297610, where C/C genotypes were associated with greater mean (systolic: 3.4 mmHg, P=0.0275; diastolic: 2.5 mmHg, P=0.0196) responses to HCTZ vs T-allele carriers. Such an association was absent in atenolol-treated participants, supporting this as HCTZ specific. Expression analyses in HCTZ-treated African-Americans showed differential pre-treatment leukocyte YEATS4 expression between rs7297610 genotype groups (P=0.024), and reduced post-treatment expression in C/C genotypes (P=0.009), but not in T-carriers. Our data confirm previous genome-wide findings at 12q15 and suggest differential YEATS4 expression could underpin rs7297610-associated HCTZ response variability, which may have future implications for guiding thiazide treatment.

KW - Blood pressure

KW - diuretics

KW - hydrochlorothiazide

KW - hypertension

KW - YEATS4

UR - http://www.scopus.com/inward/record.url?scp=84878251897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878251897&partnerID=8YFLogxK

U2 - 10.1038/tpj.2012.4

DO - 10.1038/tpj.2012.4

M3 - Article

C2 - 22350108

AN - SCOPUS:84878251897

VL - 13

SP - 257

EP - 263

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

SN - 1470-269X

IS - 3

ER -